Retraction: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites.

Wang, Maorong; Yao, Ping; Gao, Minpeng; Jin, Jian; Yu, Yerong

Wang, Maorong; Yao, Ping; Gao, Minpeng; Jin, Jian; Yu, Yerong.

Afiliación

Wang M; Department of Endocrinology, West China Hospital, Sichuan University Chengdu Sichuan 610041 China 1100312222@vip.jiangnan.edu.cn yerongyu@scu.cn.
Yao P; Department of Endocrinology, Affiliated Hospital of Hubei University for Nationalities Enshi 445000 Hubei China.
Gao M; Department of Endocrinology, Affiliated Hospital of Hubei University for Nationalities Enshi 445000 Hubei China.
Jin J; China Pharmaceutical University Nanjing Jiangsu P. R. China.
Yu Y; Jiangnan University Wuxi Jiangsu P. R. China.

RSC Adv ; 14(3): 1625, 2024 Jan 03.

Article en En | MEDLINE | ID: mdl-38179089